BridgeBio Pharma: Number of Employees 2018-2024 | BBIO
Interactive chart of BridgeBio Pharma (BBIO) annual worldwide employee count from 2018 to 2024.
- BridgeBio Pharma total number of employees in 2023 was 550, a 40.31% increase from 2022.
- BridgeBio Pharma total number of employees in 2022 was 392, a 32.18% decline from 2021.
- BridgeBio Pharma total number of employees in 2021 was 578, a 50.13% increase from 2020.
- BridgeBio Pharma total number of employees in 2020 was 385, a 55.24% increase from 2019.
| BridgeBio Pharma Annual Employee Count | |
|---|---|
| 2023 | 550 |
| 2022 | 392 |
| 2021 | 578 |
| 2020 | 385 |
| 2019 | 248 |
| 2018 | 152 |
| 2017 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $6.773B | $0.009B |
| BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $24.935B | 8.18 |
| Dr Reddy's Laboratories (RDY) | India | $12.596B | 24.10 |
| Bausch Health Cos (BHC) | Canada | $2.792B | 2.06 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.108B | 28.70 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.738B | 10.44 |
| Personalis (PSNL) | United States | $0.396B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.314B | 21.86 |
| Assembly Biosciences (ASMB) | United States | $0.095B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.025B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.006B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |